Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Setback for ABI And Caltech;Thailand “Breaks” Another Anti-HIV Patent;Pfizer Can Sell Exubera;“Rebel” Is A Generic Name And Cannot Be Registered as A Trademark;India to Offer Incentives for Drug Patents;Protiva Drops One Suit to Pursue Others;A New Patent on Technology for Gene Therapy